SG3 Management’s Immunogen Inc IMGN Stock Holding History

SG3 Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20,000	Closed	-$113K	–	1354
2021 Q3	$113K	Hold	20,000	–	–	﹤0.01%	850
2021 Q2	$132K	Buy	+20,000	New	+$140K	﹤0.01%	872

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

SG3 Management's IMGN Position: Q4 2021 in Review

SG3 Management sold out of Immunogen Inc (IMGN) in Q4 2021, closing a stake of 25,000 shares — an estimated $142K sold.

SG3 Management first reported a position in IMGN in Q1 2020 and held it in 3 quarters. The position peaked at $142K in Q3 2021. 236 funds tracked by Wall St. Rank hold IMGN as of Q4 2021.

SG3 Management reported no remaining Immunogen Inc position as of Q4 2021 after selling out during the quarter.
SG3 Management sold 25,000 Immunogen Inc shares in Q4 2021, an estimated $142K.
SG3 Management first reported a position in Immunogen Inc in Q1 2020 and held it in 3 quarters.
SG3 Management's Immunogen Inc position peaked at $142K in Q3 2021.
236 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2021.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.